World's Best Scientists 2026 revealed!
Vicente E. Torres

Vicente E. Torres

D-Index & Metrics

Medicine

D-Index
121
Citations
51872
World Ranking
3621
National Ranking
1998

Overview

Vicente E. Torres is affiliated with the Mayo Clinic in the United States and has contributed extensively to research in the fields of biochemistry, genetics, molecular biology, and medicine. Their work spans several subfields, including genetics, molecular biology, pathology and forensic medicine, nephrology, and pediatric, perinatal, and child health.

Torres's research topics predominantly focus on genetic and kidney cyst diseases, renal and related cancers, biomedical research and pathophysiology, genetic syndromes and imprinting, pediatric urology and nephrology studies, renal diseases and glomerulopathies, and fetal and pediatric neurological disorders.

Some of their recent significant papers include:

  • Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease, 2020, published in Cells
  • Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype, 2021, published in The American Journal of Human Genetics
  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure, 2023, published in Nature Medicine
  • Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy, 2021, published in American Journal of Kidney Diseases
  • The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD, 2020, published in JCI Insight

Frequent co-authors of Vicente E. Torres include:

  • Peter C. Harris
  • Fouad T. Chebib
  • Arlene B. Chapman
  • Ronald D. Perrone
  • Timothy L. Kline

The scientist's work is often published in prominent venues such as:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International
  • American Journal of Kidney Diseases
  • Kidney360

Best Publications

  • Autosomal dominant polycystic kidney disease

    Vicente E Torres;Peter C Harris;Yves Pirson

  • Tolvaptan in patients with autosomal dominant polycystic kidney disease

    Vicente E. Torres;Arlene B. Chapman;Olivier Devuyst;Olivier Devuyst;Ron T. Gansevoort

  • New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

    Lesley A Inker;Nwamaka D Eneanya;Josef Coresh;Hocine Tighiouart

  • Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

    Wko Lau;ML Blute;AL Weaver;VE Torres

  • Volume Progression in Polycystic Kidney Disease

    Jared J. Grantham;Vicente E. Torres;Arlene B. Chapman;Lisa M. Guay-Woodford

  • Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

    Vincent H Gattone;Xiaofang Wang;Peter C Harris;Vicente E Torres

  • The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

    Christopher J. Ward;Marie C. Hogan;Sandro Rossetti;Denise Walker

  • Autosomal dominant polycystic kidney disease: the last 3 years

    Vicente E. Torres;Peter C. Harris

  • Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

    Vicente E Torres;Xiaofang Wang;Qi Qian;Stefan Somlo

  • Polycystic kidney disease.

    Carsten Bergmann;Lisa M. Guay-Woodford;Peter C. Harris;Shigeo Horie

  • Defective planar cell polarity in polycystic kidney disease

    Evelyne Fischer;Emilie Legue;Antonia Doyen;Faridabano Nato

  • Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

    María V. Irazabal;Laureano J. Rangel;Eric J. Bergstralh;Sara L. Osborn

  • Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

    Vicente E Torres;Arlene B Chapman;Olivier Devuyst;Olivier Devuyst;Ron T Gansevoort

  • Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Arlene B. Chapman;Olivier Devuyst;Kai-Uwe Eckardt;Ron T. Gansevoort

  • Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

    Carmen Garcia Iglesias;Vicente E. Torres;Kenneth P. Offord;Keith E. Holley

  • Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Robert W. Schrier;Robert W. Schrier;Kaleab Z. Abebe;Ronald D. Perrone;Vicente E. Torres

  • Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

    Sandro Rossetti;Mark B. Consugar;Arlene B. Chapman;Vicente E. Torres

  • Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

    Arlene B. Chapman;Lisa M. Guay-Woodford;Jared J. Grantham;Vicente E. Torres

  • Identification and Characterization of Polycystin-2, the PKD2 Gene Product

    Yiqiang Cai;Yoshiko Maeda;Anna Cedzich;Vicente E. Torres

  • Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat

    Xiaofang Wang;Vincent Gattone;Peter C. Harris;Vicente E. Torres

Frequent Co-Authors

Peter C. Harris
Peter C. Harris Mayo Clinic
Arlene B. Chapman
Arlene B. Chapman University of Chicago
Kyongtae T. Bae
Kyongtae T. Bae University of Pittsburgh
Jared J. Grantham
Jared J. Grantham University of Kansas
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen
Olivier Devuyst
Olivier Devuyst University of Zurich
Stefan Somlo
Stefan Somlo Yale University
Robert W. Schrier
Robert W. Schrier University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering careers in medicine or healthcare, alternative degrees and online study options can provide flexibility and cost savings. There are several in-demand programs that can complement or expand your medical career without the traditional route of attending a U.S. medical school.

Pursuing a Master’s in Healthcare Administration is a popular option for those seeking leadership roles in hospitals or clinics—explore the cheapest mha online programs to find affordable pathways into healthcare management.

If you are already a nurse, consider advancing your career by looking into the cheapest bsn to dnp programs, which offer a direct and flexible track to a Doctor of Nursing Practice degree online.

Those interested in pharmacy can benefit from pharm d online programs, providing accessibility to advanced pharmaceutical training and degrees.

Finally, the rapidly growing field of health information management offers online training as well. You can prepare for the RHIA credential through rhia certification programs online, opening career doors in health data and electronic records.

Best Scientists Citing Vicente E. Torres

Trending Scientists